5-HT2 antagonist and 5-HT7 inverse agonist

brain penetrant, oral efficacy in rodent models

backup candidate to JNJ-18038683

Bioorg. Med. Chem. Lett., Nov. 7, 2020

Janssen, San Diego, CA

Structure of compound 4j

“compound 4j” (Janssen (JNJ) brain-penetrant in vivo 5-HT2 antagonist and 5-HT7 inverse agonist, backup candidate)


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: